AstraZeneca's Evusheld Retains Neutralizing Activity Against

LONDON (dpa-AFX) - AstraZeneca (AZN, AZN.L) on Thursday said its Evusheld, a long-acting antibody combination for the prevention of COVID-19, retained neutralizing activity against the Omicron

Related Keywords

Wuhan , Hubei , China , London , City Of , United Kingdom , , Astrazeneca , Drug Administration , Inhibitory Concentration , Biologics Evaluation , Executive Vice President , Evusheld , Etains , Neutralizing , Activity , Against , Micron , Variant ,